98%
921
2 minutes
20
Myocardial tissue characterization is fundamental in diagnosing, treating, and managing various cardiac diseases. In recent years, cardiac computed tomography (CCT) emerged as a valuable alternative to cardiac magnetic resonance (CMR) for myocardial tissue characterization, with the possibility to detect myocardial scar and quantify the extracellular volume fraction in a single CT study with the advantage of combined coronary arteries evaluation, shorter scanning time, and less susceptibility to device artifacts compared to CMR. However, CCT is typically affected by a lower contrast-to-noise ratio and potentially increased radiation exposure. Therefore, a deep understanding of the available technology and the strategies for acquisition optimization is of fundamental importance to improve image quality and accuracy, while minimizing radiation exposure. This review summarizes principles of myocardial characterization on CCT, acquisition protocols according to the different technologies available including the dual-energy CT and the innovative photon-counting detector CT, and setting of clinical utility.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/echo.70108 | DOI Listing |
Int J Cardiol
September 2025
Institute of Sports Medicine and Science, National Italian Olympic Committee, Largo Piero Gabrielli, 1, 00197 Rome, Italy.
Introduction: Endurance athletes are expected to present a cardiac remodeling characterized by eccentric hypertrophy. Differentiation from underlying cardiomyopathy mimicking a similar cardiac remodeling may be challenging. Myocardial work indexes (MWI) have been shown to be useful in distinguishing between physiological adaption and pathological changes in the athletes' heart.
View Article and Find Full Text PDFJ Mol Cell Cardiol
September 2025
Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address:
Selective therapeutic targeting of cardiomyocytes (CMs) and non-myocytes (NMs) within the heart is an active field of research. The success of those novel therapeutic strategies is linked to the ability to accurately assess uptake and gene delivery efficiencies in clinically relevant animal models. Nevertheless, quantification at the single cell level remains a significant challenge.
View Article and Find Full Text PDFEur J Pharm Biopharm
September 2025
Drug Research Program, Faculty of Pharmacy, University of Helsinki, Finland; Individualized Drug Therapy Research Program, University of Helsinki, Finland; Wihuri Research Institute, Helsinki, Finland; Helsinki One Health, Helsinki, Finland. Electronic address:
Vascular Endothelial Growth Factor C (VEGFC) is a promising biological drug, with preclinical studies indicating its potential for treating myocardial infarction, neurodegenerative diseases, and lymphedema, a condition that currently lacks curative treatment. While adenoviral VEGFC gene therapy has progressed to phase II studies, its clinical efficacy is limited by rapid immune inactivation. This study explores lignin nanoparticles (LNPs) as an alternative VEGFC delivery system.
View Article and Find Full Text PDFAdv Sci (Weinh)
September 2025
Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, P. R. China.
Mitigating myocardial ischemia-reperfusion (IR) injury is essential for enhancing the success of heart transplantation (HT) and improving patient outcomes. During HT, infiltrating neutrophils are influenced and regulated by various other cell types, contributing to myocardial IR injury through the excessive release of neutrophil extracellular traps (NETs). Nonetheless, the precise mechanisms underlying the interactions between neutrophils and other non-cardiomyocytes remain largely unexplored.
View Article and Find Full Text PDFJACC Case Rep
September 2025
Cardiology Unit, Cardiovascular Department, Humanitas Gavazzeni, Bergamo, Italy.
Background: We present a multimodality imaging study of a rare case of postsurgical chronically evolved pseudoaneurysm with a possible rupture buffered by the huge thrombus.
Case Summary: A patient known for previous late presentation myocardial infarction complicated by shock and ventricular septal defect and treated with surgical repair and triple coronary artery bypass grafting, was directed to our hospital for severe mitral regurgitation. Computed tomography, cardiac magnetic resonance, and echocardiography, in a multimodality approach, revealed a huge postsurgical cardiac pseudoaneurysm, with an extensive thrombus and the native pericardium not perfectly distinguishable from pseudoaneurysm tissue or surgical patch.